Please login to the form below

Not currently logged in

Alexion begins work on new global headquarters

Rare diseases drug company will move to new US site in 2015

Alexion Pharmaceuticals New Haven ground breaking
From left: New Haven Mayor John DeStefano, Sen. Richard Blumenthal, Governor Dan Malloy, Alexion CEO Leonard Bell, Rep. Rosa Delauro and Yale University VP Bruce Alexander (photo: Business Wire)

Alexion Pharmaceuticals has broken ground on the site for its new global headquarters in New Haven, Connecticut.

The rare diseases specialist will occupy nine floors at the College Street site and expects to move across the state from its current Cheshire base to take residency at the site in 2015.

Leonard Bell, chief executive officer of Alexion, said: "Our new global headquarters will support our continued growth as we work to develop and deliver life-transforming therapies for patients with severe and life-threatening disorders that are also ultra-rare.

“We are especially pleased by this step because our return to New Haven is a homecoming for our company, and we are able to take part in the redevelopment of the downtown area.”

Alexion was founded 20 years ago in New Haven and currently employs more than 400 people at its present Connecticut site.

Sales of its lead terminal complement inhibitor Soliris (eculizumab) last year topped $1.1bn and asfotase alfa, its treatment for the inherited metabolic disorder hypophosphatasia that last month received breakthrough status from the FDA, could give the company a second big-selling product.

Once the company's new HQ is ready they will be relocated to New Haven, where Alexion plans to add up to another 300 new jobs as part of its expansion plans.

Article by
Dominic Tyer

19th June 2013

From: Research, Sales



Featured jobs

Subscribe to our email news alerts


Add my company

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...